Text analysis of proprietary drug name interpretations

Ended Awarded Last action

Contract number
75F40120F19004
Awardee
Awarding agency
Obligated
$838,616

Award facts

Contract value 100% obligated
$838,616.34 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Set-aside
No set-aside
Competition
Full and Open Competition Multiple Award, Fair Opportunity
Pricing
Firm Fixed Price
Place of performance
Durham, NC 27709, USA
Legislative mandates

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Close Out P00003 -$20,047
Other Administrative Action P00002 $0
Change Order P00001 $0
Original award $858,663

About this award

This contract award represents a Blanket Purchase Agreement (BPA) call issued by the Food and Drug Administration (FDA) to Research Triangle Institute (RTI International) for text analysis of proprietary drug name interpretations. The contract was awarded on August 31, 2020, with a ceiling value of $838,616.34 under a firm fixed-price pricing structure. RTI International, a prominent nonprofit research organization headquartered in Research Triangle Park, North Carolina, was selected to perform this work at its primary location in Research Triangle Park. The contract is not designated as a set-aside and operates under the GSA Multiple Award Schedule (MAS). This engagement reflects the FDA's utilization of RTI's established analytical and research capabilities, which the organization has demonstrated across numerous health-related federal initiatives and regulatory support services.

The contract includes a subcontract awarded to Ipsos Public Affairs, LLC on September 13, 2021, under subcontract number 2-312-0217597. Ipsos Public Affairs, a Connecticut-based market research firm specializing in survey design and data analysis for federal agencies, serves as a key subcontractor supporting the text analysis work. The ultimate completion date for this contract was September 7, 2024. This engagement leverages RTI's extensive FDA contract portfolio, which has previously encompassed tobacco laboratory analysis, youth tobacco survey support, opioid prescribing research, and public education campaign evaluations, positioning the organization to deliver specialized analytical services in support of the FDA's regulatory and policy objectives.

Quick answers

Who was awarded contract 75F40120F19004?

75F40120F19004 was awarded to Research Triangle Institute by Food and Drug Administration (Department of Health and Human Services) on August 31, 2020.

How much is contract 75F40120F19004 worth?

The government has obligated $838,616 on 75F40120F19004.

Is contract 75F40120F19004 an order under another contract?

Yes. 75F40120F19004 is a BPA call under GS00F354CA-75F40120A00017, a blanket purchase agreement, on Multiple Award Schedule (MAS).

Was contract 75F40120F19004 competed?

The extent of competition for 75F40120F19004 was full and open competition.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award